Efficacy of topiramate and topiramate with omega-3 fatty acid in prophylaxis of children migraine headaches
Phase 2
- Conditions
- migraine headache.Migraine
- Registration Number
- IRCT20091027002639N23
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
children aged 5-15 years old
having migraine headache based on International Headache Society Criteria
having one or more headache attack per week
having moderate or severe headache disability
have not received omega-3 combinations within the past two months
did not use any migraine preventive therapy
Exclusion Criteria
secondary headaches such as epilepsy or other neurologic disorders
allergy to topiramat or omega-3
discontinuation of drugs usage for more than one week
irregullar drugs usage
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method